Pharma · Private company
Teva Pharmaceutical Industries, Ltd.
Track this companyFree. Adds Teva Pharmaceutical Industries, Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and HipPHASE2 · TERMINATED · started Apr 8, 2019ClinicalTrials.gov NCT03949673 · fetched Nov 12, 2026
- To Assess the Patients' Ability to Self-Administer FasinumabPHASE1 · COMPLETED · started Jan 23, 2019ClinicalTrials.gov NCT03491904 · fetched Nov 12, 2026
- Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or KneePHASE2 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03691974 · fetched Nov 12, 2026
- Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or KneePHASE3 · TERMINATED · started Oct 30, 2017ClinicalTrials.gov NCT03285646 · fetched Nov 12, 2026
- Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or HipPHASE3 · COMPLETED · started Oct 26, 2017ClinicalTrials.gov NCT03304379 · fetched Nov 12, 2026
- A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or HipPHASE3 · COMPLETED · started Aug 17, 2017ClinicalTrials.gov NCT03161093 · fetched Nov 12, 2026
- Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or HipPHASE3 · COMPLETED · started Feb 17, 2016ClinicalTrials.gov NCT02683239 · fetched Nov 12, 2026